Press

Go to press materials
Go back to news
  • All News
  • Product News
  • Corporate News
  • The Medipac container range from RPC Astrapak Plastop has been developed to meet the wide-ranging requirements of the prescriptive medicines and wellness supplements markets. With products coming in a variety of shapes and sizes and requiring a multitude of doses, the choice of containers in the Medipac range makes them ideal for all types of tablets, capsules and supplements, and enables brands to maintain continuity, regardless of the dose.

  • RPC Formatec, part of the RPC Bramlage Division, has extended its range of state-of-the-art inhalers with the introduction of a new optimised breath-actuated pressurised Metered-Dose Inhaler (pMDI). The inhaler’s rounded design with large mouthpiece provides easy handling and maximum comfort for the user.

  • RPC Formatec, part of the RPC Bramlage Division, has launched a new inhaler that delivers enhanced levels of patient convenience, comfort and safety.

  • Probiotic specialist Yun Probiotherapy is using the Magic Star airless dispenser and Vario overcap from RPC Bramlage for its revolutionary range of unique treatments for personal care and common to more severe skin concerns.

  • A new 19mm tube closure from RPC Zeller Plastik Zell is the first standard push-on flip-top hinge tube closure (HTC) of such a small size. Aimed at cosmetic and pharmaceutical products, the new-size polypropylene closure extends RPC Zeller’s existing Supersoft range with a solution that offers both aesthetic and consumer-convenience benefits.

  • RPC Zeller Plastik Zell has extended its screw-on Classic range of polypropylene hinge tube closures (HTC) with the addition of a 25mm size, available with a matt finish. The new closure joins existing 50mm, 40mm, 35mm and 30mm sizes enabling brand manufacturers to create family ranges using a single closure design. Its contemporary look meets current market trends for a more modern and edgy appearance on-shelf.

  • Plastiape has officially been acquired by the RPC Group to become RPC Plastiape. Plastiape's acquisition will place it in the RPC Bramlage Division. The move is part of the RPC Group's strategy to build and enhance a growth platform in the health care sector. RPC's Bramlage Division therefore expands from five to six sub-divisions.

  • RPC Bramlage-Wiko has launched a new inhaler to meet the growing demand for capsule-based systems. The new Capsuhale is a novel capsule-based dry powder inhaler with passive dispersion, and features a flow rate that is adjustable to suit the needs of different drug types.

  • The RS01 concept was brought into existence by Plastiape over the last decade as a result of the intensive refinement of previous monodose-in-capsule device designs, manufactured by the company since the late 1970s. Patented, manufactured, and marketed by Plastiape, the RS01 has many distinctive features, including a sleek, refined design and the simple fact that it is a product that actually works the way it should.

  • The latest generation single-dose per capsule inhaler is the Monodose RS01 developed by Plastiape. Compared with the more sophisticated multi-dose and other single-dose inhalers on the market, the RS01 is notable for its compact size, reduced number of parts and for the simplicity and effectiveness of its perforation system, suited to both gelatine and HMPC capsules.